GARDASIL 40 ug/.5mL (Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant INJECTION, SUSPENSION) 40 ug/.5mL

GARDASIL 40 ug/0.5mL is a quadrivalent HPV vaccine designed to protect against certain types of human papillomavirus. This recombinant vaccine is administered intramuscularly and is intended for preventive use.

Strength

40 ug/.5mL

Pack Size

6 SYRINGE in 1 CARTON (0006-4109-09) / .5 mL in 1 SYRINGE (0006-4109-01)

Manufacturer / TM Owner

Merck Sharp & Dohme LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

GARDASIL 40 ug/0.5mL is primarily used to prevent infections caused by human papillomavirus types 6, 11, 16, and 18. These types are associated with various health issues, including genital warts and certain cancers. The vaccine is often recommended for individuals to help reduce the risk of these conditions. What is GARDASIL used for? It is used for the prevention of HPV-related diseases, supporting overall health and well-being.

Side Effects

Common effects of GARDASIL 40 ug/0.5mL may include mild to moderate reactions at the injection site, such as pain, swelling, or redness. Some individuals might experience temporary symptoms like headache, fatigue, or mild fever. These effects are generally short-lived and resolve on their own.

Precautions & Warnings

GARDASIL 40 ug/0.5mL should be handled and stored according to the manufacturer's guidelines to maintain its efficacy. It is important to inform healthcare providers about any allergies or medical conditions before administration. Follow the recommended schedule for optimal protection.

Avoid Interactions

GARDASIL 40 ug/0.5mL may interact with certain medications or health conditions. It is advisable to discuss any current medications or health issues with a healthcare provider before receiving the vaccine. Avoid alcohol or other substances that may affect the immune system.

Frequently Asked Questions

GARDASIL 40 ug/0.5mL is used to prevent infections caused by human papillomavirus types 6, 11, 16, and 18, which are linked to genital warts and certain cancers.

GARDASIL 40 ug/0.5mL is administered intramuscularly, typically in the upper arm or thigh, following a recommended schedule.

Common side effects may include pain, swelling, or redness at the injection site, as well as temporary symptoms like headache or mild fever.

Individuals with a history of severe allergic reactions to any component of the vaccine or those with certain medical conditions should consult a healthcare provider before receiving GARDASIL 40 ug/0.5mL.

It is important to discuss any current medications or health issues with a healthcare provider to ensure the safe administration of GARDASIL 40 ug/0.5mL.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.